Clin2
NCT07146594Possibly a fitNot yet recruiting

14-day bismuth therapy for H. pylori infection

Helicobacter Pylori GastritisHelicobacter Eradication

Part of Digestive system, Infections clinical trials.

This trial tests a 14-day treatment with bismuth and several antibiotics to see if it can successfully clear H. pylori infection. It is designed for people with stomach pain (dyspepsia) or low iron who are found to have H. pylori during an endoscopy.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
150 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years or older
  • You have stomach pain (dyspepsia) or iron deficiency anemia
  • You are scheduled for an upper GI endoscopy
  • You test positive for H. pylori infection
  • You have not taken bismuth-based H. pylori treatment before
  • You have not used antibiotics, bismuth, NSAIDs, or aspirin in the last month, or PPIs in the last two weeks

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT04527055Enrolling by invitation· Phase 4
Bismuth treatment for H. pylori: 10 or 14 days

This trial compares two common stomach medicine plans that use bismuth for 10 days versus 14 days to clear an H. pylori infection. It may help you find a shorter or more effective treatment schedule if you have H. pylori confirmed by an endoscopy.

Tainan
NCT07142798Enrolling by invitation
14-day triple therapy for H. pylori infection

This trial tests a 14-day treatment using bismuth, amoxicillin, and a stomach acid reducer (PCAB) to see how well it clears H. pylori, a bacteria that can cause stomach ulcers. It may be an option if you have H. pylori and haven't had stomach surgery or certain serious health conditions.

Kaohsiung City
NCT07576959Recruiting· Phase 3
Bismuth with dual therapy for H. pylori infection treatment

This trial tests whether adding bismuth (a mineral compound) to standard two-drug therapy helps cure H. pylori, a common stomach bacteria that can cause ulcers and inflammation. The goal is to see if this combination works better than dual therapy alone.

Taipei
NCT06731023Not yet recruiting
Treating Stubborn H. pylori with Tailored Bismuth Quadruple Therapy

This study tests whether a 14-day treatment with bismuth and four drugs, chosen based on lab tests showing which antibiotics still work, can clear an extremely stubborn H. pylori infection that hasn't gone away after at least two prior treatments.

Jinan, Shandong
NCT07260006Recruiting
Bismuth therapy for H. pylori ulcers in children

This trial tests whether adding bismuth to standard treatment works better for children with stomach ulcers caused by H. pylori infection. If your child has been diagnosed with an H. pylori ulcer, this study could help find the best medicine.

Can Tho
NCT06168214Recruiting· Phase 4
Comparing treatments for H. pylori infection

This study compares several different 2-week treatment plans to see which works best for wiping out H. pylori, a bacteria that can cause stomach ulcers and other digestive problems. If you have H. pylori, you may be able to join and receive one of the treatments.

Xi'an, Shaanxi

Hear when a new Helicobacter Pylori Gastritis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.